The global veterinary diagnostics market size reached USD 7.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.0 Billion by 2033, exhibiting a growth rate (CAGR) of 6.97% during 2025-2033. The growing number of pet ownerships, increasing demand for preventive care of pets, and rising awareness about zoonotic diseases, which can be transmitted between animals and humans, are some of the major factors propelling the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 7.1 Billion |
Market Forecast in 2033 | USD 13.0 Billion |
Market Growth Rate (2025-2033) | 6.97% |
Rising number of pet ownerships
At present, there is a rise in the number of pet ownership worldwide, driven by changing lifestyles, urbanization, and the growing awareness about the health benefits associated with pet companionship. Pets offer unconditional love, loyalty, and can be a source of comfort and stress relief. Apart from this, the availability of pet-related resources, such as pet stores, veterinary services, pet-friendly establishments, and online platforms, for purchasing pet supplies, is making pet ownership more accessible and convenient. Moreover, the increasing awareness and concern about animal welfare is playing a significant role in the rise of pet ownership. People are increasingly adopting pets from animal shelters and rescue organizations, giving abandoned or neglected animals a better care. Furthermore, as more people consider their pets as family members, the demand for veterinary diagnostics is increasing around the world. The veterinary diagnostics market research highlights an expanding industry landscape, underpinned by evolving technological innovations, increasing pet ownership.
Increasing emergence of advanced diagnostic technologies
Advanced diagnostic technologies are revolutionizing veterinary diagnostics, enabling more accurate and efficient identification of diseases and health conditions in animals. It involves the analysis of genetic material to detect and identify specific pathogens, genetic abnormalities, and disease markers. Apart from this, various techniques, such as polymerase chain reaction (PCR), real-time PCR, deoxyribonucleic acid (DNA) sequencing, and microarrays, allow for the detection of infectious agents, genetic diseases, and cancer mutations with high sensitivity and specificity. Advanced veterinary diagnostic techniques are also useful for detecting complex fractures, and tumors. It provides superior visualization of the brain, spinal cord, joints, and soft tissue structures.
Increasing awareness about preventive care of pets
At present, there is an increase in awareness about preventive care of pets as it enhances the overall health conditions of animals and improves their survival rates. Apart from this, online resources, websites, forums, and social media platforms provide pet owners with information on preventive measures, routine vaccinations, wellness screenings, and the importance of regular veterinary check-ups. This, in turn, is empowering pet owners to take proactive measures in caring for their pets. Moreover, advancements in veterinary diagnostics are contributing to the awareness and importance of preventive care. Veterinary professionals are acquiring a better understanding of disease prevention, vaccination schedules, and the benefits of regular screenings. They can educate pet owners about preventive care measures and provide evidence-based recommendations for keeping pets healthy. Moreover, the veterinary diagnostics market forecast reveals heightened demand for veterinary services due to the increasing emphasis on animal health.
IMARC Group provides an analysis of the key trends in each segment of the global veterinary diagnostics market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on product, technology, animal type, disease type and end user.
Breakup by Product:
Kits and reagents dominate the market
The report has provided a detailed breakup and analysis of the market based on the product. This includes instruments, kits and reagents, and software and services. According to the report, kits and reagents represented the largest segment.
Kits and reagents play a crucial role in veterinary diagnostics and provide essential tools and substances for conducting various diagnostic tests. They include pre-packaged reagents and instructions for conducting tests, such as enzyme-linked immunosorbent assays (ELISAs) or polymerase chain reaction (PCR) assays. The reagents in these kits are designed to detect specific pathogens or disease markers, allowing veterinarians to diagnose infectious diseases spontaneously and accurately in animals. They are also used to measure parameters, such as complete blood counts, blood chemistries (including liver and kidney function), electrolyte levels, and blood clotting abilities. They assist in detecting abnormalities, such as the presence of bacteria, parasites, blood, or abnormal levels of certain chemicals or metabolites.
Breakup by Technology:
Clinical biochemistry holds the largest share in the market
A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, and others. According to the report, clinical biochemistry accounted for the largest market share.
Clinical biochemistry is a fundamental component of veterinary diagnostics that involves the analysis of blood and other body fluids to assess the physiological and biochemical status of animals. It provides valuable information about organ function, metabolic processes, and the presence of diseases or abnormalities. It helps measure a wide range of parameters, including enzymes, electrolytes, proteins, metabolites, hormones, and waste products. It encompasses various tests, which are conducted using specialized laboratory equipment and reagents. It also focuses on providing quantitative data that helps veterinarians in the diagnosis, monitoring, and treatment of various conditions. Furthermore, by evaluating the levels of specific analytes in the blood, such as liver enzymes, kidney function markers (creatinine), glucose, albumin, and electrolytes (sodium and potassium), clinical biochemistry aids in the detection of organ dysfunction, nutritional imbalances, endocrine disorders, and metabolic abnormalities in animals.
Breakup by Animal Type:
Livestock animals hold the maximum share of the market
A detailed breakup and analysis of the market based on the animal type have also been provided in the report. This includes companion animals (dogs, cats, and others) and livestock animals (cattle, swine, poultry, and others). According to the report, livestock animals (cattle, swine, poultry, and others) accounted for the largest market share.
Livestock animals, such as cattle, pigs, sheep, and poultry, require veterinary diagnostics as it helps identify and diagnose diseases effectively. Early detection is crucial for implementing appropriate control measures to restrict the spread of infectious diseases within herds or flocks. Besides this, diagnostic tests enable veterinarians to accurately identify the causative agents, determine the extent of disease prevalence, and guide the implementation of effective treatment and preventive strategies. Veterinary diagnostic testing also helps assess the health and productivity of individual animals and the overall herd or flock. By monitoring various parameters, such as blood chemistry, fecal quality, and growth rates, veterinarians can identify and address health issues that may affect production efficiency, including nutritional deficiencies, parasitic infections, metabolic disorders, and respiratory diseases.
Breakup by Disease Type:
Non-infectious diseases account for the majority of market share
A detailed breakup and analysis of the market based on the disease type have also been provided in the report. This includes infectious diseases, non-infectious diseases, hereditary, congenital, and acquired diseases, general ailments, and structural and functional diseases. According to the report, non-infectious diseases accounted for the largest market share.
Veterinary diagnostics play a crucial role in identifying infectious diseases in animals, as accurate and timely diagnosis is essential for appropriate treatment and control measures. It is essential for disease surveillance and monitoring in animal populations. By conducting diagnostic tests on individual animals or within herds or flocks, veterinarians can assess the prevalence, spread, and impact of infectious diseases. It also aids in identifying various zoonotic diseases in animals, helping prevent or minimize the transmission of pathogens from animals to humans. By diagnosing and managing infectious diseases in animals, veterinary diagnostics contribute to protect public health and prevent the spread of zoonotic infections.
Breakup by End User:
Reference laboratories hold the largest share in the market
A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes reference laboratories, veterinary hospitals and clinics, and others. According to the report, reference laboratories accounted for the largest market share.
Reference laboratories play a vital role in veterinary diagnostics by providing specialized and advanced diagnostic services to support veterinarians, clinics, and research institutions. They are equipped with state-of-the-art technology, highly trained personnel, and expertise in a wide range of veterinary diagnostic disciplines. They offer a comprehensive number of diagnostic tests that may not be available at local veterinary clinics or laboratories. They often possess a broader test menu and the capacity to perform essential tests that require specialized equipment, techniques, or expertise. Reference laboratories can perform highly specific and sensitive tests to detect infectious agents, identify genetic disorders, diagnose complex diseases, and assess the overall health status of animals.
Breakup by Region:
North America exhibits a clear dominance, accounting for the largest veterinary diagnostics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest market share due to the increase in veterinary specialty practices and referral centers. Besides this, the rising focus on pet health and wellness and advanced veterinary medicine is propelling the growth of the market.
Another contributing aspect is the increasing demand for preventive healthcare, early disease detection, and personalized treatment options to ensure their pets lead long and healthy lives is offering a favorable veterinary diagnostics market outlook.
Asia Pacific is estimated to expand further in this domain due to rising adoption of pets among millennials. Besides this, the increasing expansion of livestock and aquaculture industries is bolstering the growth of the market.
Key market players in the market are implementing various strategies and initiatives to improve their business. They are investing in research and development (R&D) activities to innovate and develop new diagnostic technologies, tests, and products. They are also focusing on improving the accuracy, efficiency, and speed of veterinary diagnostic tests, as well as expanding the range of diseases and conditions that can be diagnosed. Top companies are actively pursuing strategic partnerships and acquisitions to expand their product offerings, geographical reach, and market share. They are also providing telemedicine services to pet owners, comprising of consultation, monitoring, and remote diagnostic in certain scenarios. Leading companies are embracing artificial intelligence (AI), machine learning (ML), and molecular diagnostics to improve their product offerings and service delivery.
The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Products Covered | Instruments, Kits and Reagents, Software and Services |
Technologies Covered | Immunodiagnostics, Clinical Biochemistry, Molecular Diagnostics, Hematology, Others |
Animal Types Covered |
|
Disease Types Covered | Infectious Diseases, Non-infectious Diseases, Hereditary, Congenital and Acquired Diseases, General Ailments, Structural and Functional Diseases |
End Users Covered | Reference Laboratories, Veterinary Hospitals and Clinics, Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | BioChek B.V., Biomérieux SA, Heska Corporation, IDEXX Laboratories Inc., IDvet, Neogen Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Virbac, Zoetis Inc., etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global veterinary diagnostics market was valued at USD 7.1 Billion in 2024.
We expect the global veterinary diagnostics market to exhibit a CAGR of 6.97% during 2025-2033.
The rising number of pet clinics, along with the growing advancements in veterinary diagnostics for improving the accuracy and efficiency and speed of diagnostic tests, are primarily driving the global veterinary diagnostics market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective diseases, injuries, and other health conditions treatment procedures in animals to reduce the risk of the coronavirus infection upon hospital visits and interaction with healthcare professionals, thereby negatively impacting the global market for veterinary diagnostics.
Based on the product, the global veterinary diagnostics market can be segmented into instruments, kits and reagents, and software and services. Currently, kits and reagents hold the largest market share.
Based on the technology, the global veterinary diagnostics market has been divided into immunodiagnostics, clinical biochemistry, molecular diagnostics, hematology, and others, where clinical biochemistry currently exhibits a clear dominance in the market.
Based on the animal type, the global veterinary diagnostics market can be categorized into companion animals and livestock animals. Currently, livestock animals account for the majority of the global market share.
Based on the disease type, the global veterinary diagnostics market has been segregated into infectious diseases, non-infectious diseases, hereditary, congenital, and acquired diseases, general ailments, and structural and functional diseases. Among these, non-infectious diseases hold the largest market share.
Based on the end user, the global veterinary diagnostics market can be bifurcated into reference laboratories, veterinary hospitals and clinics, and others. Currently, reference laboratories exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global veterinary diagnostics market include BioChek B.V., Biomérieux SA, Heska Corporation, IDvet, IDEXX Laboratories Inc., Neogen Corporation, Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Virbac, Zoetis Inc, etc.